MARKER THERAPEUTICS INC's ticker is MRKR and the CUSIP is 57055L107. A total of 61 filers reported holding MARKER THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $186 | – | 700 | 0.0% | 0.00% | – |
| Q3 2022 | $0 | – | 700 | 0.0% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 700 | 0.0% | 0.00% | – |
| Q1 2022 | $1,000 | – | 700 | 0.0% | 0.00% | – |
| Q4 2021 | $0 | -100.0% | 700 | 0.0% | 0.00% | – |
| Q3 2021 | $1,000 | -50.0% | 700 | 0.0% | 0.00% | – |
| Q2 2021 | $2,000 | 0.0% | 700 | 0.0% | 0.00% | – |
| Q1 2021 | $2,000 | +100.0% | 700 | 0.0% | 0.00% | – |
| Q4 2020 | $1,000 | 0.0% | 700 | 0.0% | 0.00% | – |
| Q3 2020 | $1,000 | 0.0% | 700 | 0.0% | 0.00% | – |
| Q2 2020 | $1,000 | 0.0% | 700 | 0.0% | 0.00% | – |
| Q1 2020 | $1,000 | 0.0% | 700 | +40.0% | 0.00% | – |
| Q4 2019 | $1,000 | -66.7% | 500 | 0.0% | 0.00% | – |
| Q3 2019 | $3,000 | -25.0% | 500 | 0.0% | 0.00% | – |
| Q2 2019 | $4,000 | +33.3% | 500 | 0.0% | 0.00% | – |
| Q1 2019 | $3,000 | 0.0% | 500 | 0.0% | 0.00% | – |
| Q4 2018 | $3,000 | – | 500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AR ASSET MANAGEMENT INC | 70,700 | $321 | 0.09% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |